Latest MedImmune Stories
AVP-825 uses novel Breath Powered(TM) drug delivery to treat migraine YARDLEY, Pa., Jan.
SINGAPORE and ZURICH, January 29, 2014 /PRNewswire/ -- Singapore's Agency for Science, Technology and Research (A*STAR) and Switzerland's Cytos Biotechnology AG today announced
-- Joseph Sliman, M.D., M.P.H., Joins Team as Senior Vice President, Clinical & Regulatory Affairs -- ROCKVILLE, Md., Jan. 27, 2014 /PRNewswire/ -- Synthetic Biologics, Inc.
LONDON and BOSTON, January 23, 2014 /PRNewswire/ -- Stabilised GPCR (StaR(R)) Proteins Delivered For All Nominated Targets Heptares Therapeutics,
Easy Protection from Flu Virus Now Available to Houston Residents Houston, TX (PRWEB) November 22, 2013 With flu season almost here, many residents across
Reportbuyer.com just published a new market research report: